Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention

Sleep-disordered breathing (SDB) has been associated with insulin resistance and glucose intolerance, and is frequently found in people with type 2 diabetes. SDB not only causes poor sleep quality and daytime sleepiness, but has clinical consequences, including hypertension and increased risk of car...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes research and clinical practice 2008-07, Vol.81 (1), p.2-12
Hauptverfasser:	Shaw, Jonathan E, Punjabi, Naresh M, Wilding, John P, Alberti, K George M M, Zimmet, Paul Z
Format:	Artikel
Sprache:	eng
Schlagworte:	Continuous Positive Airway Pressure Depression - etiology Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - prevention & control Fatigue Glucose - metabolism Glucose Intolerance - etiology Humans Memory Disorders - etiology Oxygen Consumption Respiratory Tract Diseases - complications Respiratory Tract Diseases - epidemiology Respiratory Tract Diseases - therapy Sleep Apnea, Obstructive - complications Sleep Apnea, Obstructive - epidemiology Sleep Apnea, Obstructive - physiopathology Sleep Apnea, Obstructive - therapy Sleep Wake Disorders - complications Sleep Wake Disorders - epidemiology Sleep Wake Disorders - physiopathology Sleep Wake Disorders - therapy Snoring - etiology Societies, Medical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Sleep-disordered breathing (SDB) has been associated with insulin resistance and glucose intolerance, and is frequently found in people with type 2 diabetes. SDB not only causes poor sleep quality and daytime sleepiness, but has clinical consequences, including hypertension and increased risk of cardiovascular disease. In addition to supporting the need for further research into the links between SDB and diabetes, the International Diabetes Federation Taskforce on Epidemiology and Prevention strongly recommends that health professionals working in both type 2 diabetes and SDB adopt clinical practices to ensure that a patient presenting with one condition is considered for the other.
ISSN:	1872-8227
DOI:	10.1016/j.diabres.2008.04.025